| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |